NS · Pharmaceuticals

Procter & Gamble Health Ltd (PGHL)

Pharmaceuticals & Biotechnology

Procter & Gamble Health Ltd (PGHL) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $102.92B, P/E ratio is 31.48, net margin is 21.7%, dividend yield is 2.58%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for PGHL

Market cap

$102.92B

P/E ratio

31.48

Net margin

21.7%

Dividend yield

2.58%

Procter & Gamble Health Ltd (PGHL) — FAQ

What is Procter & Gamble Health Ltd's market cap?

Procter & Gamble Health Ltd (PGHL) has a reported market cap of $102.92B (data as of 2026-07-10).

What is PGHL's P/E ratio?

The price-to-earnings (P/E) ratio for Procter & Gamble Health Ltd (PGHL) is 31.48 (data as of 2026-07-10).

Does Procter & Gamble Health Ltd pay a dividend?

Procter & Gamble Health Ltd (PGHL) shows a reported dividend yield of 2.58%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Procter & Gamble Health Ltd in?

Procter & Gamble Health Ltd (PGHL) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is PGHL listed on?

PGHL is listed on NS.

What is Procter & Gamble Health Ltd's net margin?

Procter & Gamble Health Ltd (PGHL) reports a net margin of 21.7% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)